Jazz Pharmaceuticals JAZZ Work in process
Work in process at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryWorkInProcessNetOfReserves.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's work in process.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's work in process?
- Jazz Pharmaceuticals (JAZZ) reported work in process of $290.4M in Q1 2026.
- How has Jazz Pharmaceuticals's work in process changed year-over-year?
- Jazz Pharmaceuticals's work in process decreased by 9.3% year-over-year, from $320.25M to $290.4M.
- What is the long-term trend for Jazz Pharmaceuticals's work in process?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's work in process has grown at a 40.8% compound annual growth rate (CAGR), from $45.76M to $253.4M.